Not applicableUnknownNCT02992990What this trial is testingBladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and GradeWho this might be right forBladder Cancer Baylor College of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT04383743What this trial is testingPembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder CancerWho this might be right forStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma University of Washington 17
Not applicableAvailableNCT06443944What this trial is testingAn Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGWho this might be right forNon-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more CG Oncology, Inc.
Not applicableUnknownNCT05276167What this trial is testingHyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial CarcinomaWho this might be right forHigh-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Not applicableLooking for participantsNCT06991868What this trial is testingProspective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)Who this might be right forNMIBCMIBCUTUC Peking University First Hospital 300
Large-scale testing (Phase 3)Study completedNCT00729287What this trial is testingSelenium in Preventing Cancer Recurrence in Patients With Bladder CancerWho this might be right forBladder Cancer KU Leuven 276
Testing effectiveness (Phase 2)UnknownNCT04730232What this trial is testingTilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely ResectableWho this might be right forHigh-RiskNon-Muscle Invasive Bladder Urothelial Carcinoma Tianjin Medical University Second Hospital 63
Testing effectiveness (Phase 2)Study completedNCT03914794What this trial is testingPemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk TumorsWho this might be right forBladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Looking for participantsNCT06766266What this trial is testingIrinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines TreatmentWho this might be right forNon-Muscle Invasive Bladder Urothelial Carcinoma First Affiliated Hospital of Chongqing Medical University 18
Not applicableLooking for participantsNCT07302230What this trial is testingHome-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER TrialWho this might be right forLocalized Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more University of Washington 100
Testing effectiveness (Phase 2)Study completedNCT01687244What this trial is testingIntravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder CancerWho this might be right forSuperficial Bladder Cancer FKD Therapies Oy 40
Testing effectiveness (Phase 2)Study completedNCT02015104What this trial is testingStudy of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCGWho this might be right forBladder Cancer National Cancer Institute (NCI) 32
Very early researchStudy completedNCT00734994What this trial is testingMitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder CancerWho this might be right forTransitional Cell Carcinoma of BladderSuperficial Bladder Cancer Mark Dewhirst 15
Not applicableStudy completedNCT06818799What this trial is testingThulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder CancerWho this might be right forBladder Transitional Cell Carcinoma Helwan University 50
Early research (Phase 1)Active Not RecruitingNCT05768347What this trial is testingIntravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBCWho this might be right forUrothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma H. Lee Moffitt Cancer Center and Research Institute 9
Large-scale testing (Phase 3)Looking for participantsNCT05037279What this trial is testingEvaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)Who this might be right forBladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more Verity Pharmaceuticals Inc. 540
Post-approval studies (Phase 4)Looking for participantsNCT05962541What this trial is testingVesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)Who this might be right forNon-muscle-invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial CarcinomaHigh Risk Non-Muscle Invasive Bladder Urothelial Carcinoma University of Roma La Sapienza 327
Large-scale testing (Phase 3)Not Yet RecruitingNCT07464145What this trial is testingNDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder CancerWho this might be right forBladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder+2 more Relmada Therapeutics, Inc. 393
Early research (Phase 1)Study completedNCT02808143What this trial is testingPembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder CancerWho this might be right forRecurrent Bladder CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+1 more Northwestern University 9